Pay in 4 interest-free payments of $6.66 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Protocol Quick-Reference Lean mass preservation during GLP-1 agonist weight loss therapy Dosing Amount 200-400 mg Frequency Subcutaneous injection (dosing interval not publicly specified) Duration 26-week weight-loss phase followed by 26-week maintenance Administration Route SC Schedule Periodic subcutaneous injection (interval not disclosed) Timing Administered in combination with semaglutide 2.4 mg SC weekly in the COURAGE trial
This formulary-driven shift in obesity treatment patterns has important implications for patients
Both B12 and B complex shots are given using either intramuscular or subcutaneous injections
Most semaglutide formulations from licensed 503A compounding pharmacies are designed for refrigeration between 36F and 46F, not freezer storage at 0F or below
US$ 27.23
US$ 25.43
US$ 25.01
US$ 29.19
US$ 27.18
US$ 23.13
